oVi by OpenVial
Engineered for early-stage innovation, oVi™ is a sterile, pre-tested, double-packed vial system ready for immediate use.
Purpose-built to support early-stage research and development, oVi™ streamlines workflows and ensures uncompromising reliability for companies pushing the boundaries of healthcare. Designed and developed by OpenVial, oVi™ delivers a seamless solution tailored to the needs of pioneering research.
Pyrogen Free.
Adhering to USP and EP Standards.
Each oVi™ vial is rigorously tested to be free of pyrogenic substances, meeting the requirements of the United States Pharmacopeia (USP) and European Pharmacopeia (EP). These tests ensure that our vials do not induce febrile reactions, making them suitable for injectable solutions and sensitive biologicals.
Tested per USP <85> and EP 2.6.14
Eliminates risks of pyrogen-induced immune responses
Suitable for endotoxin-sensitive applications
Sterile.
Meeting Regulatory Sterility Standards.
oVi™ vials comply with international sterility regulations, ensuring a controlled, contamination-free environment for critical applications. Produced under GMP-compliant conditions, our vials are sterilized using validated processes to meet the most rigorous pharmaceutical standards.
Manufactured in ISO 5 cleanrooms
Terminal sterilization validated per ISO 11137
Designed for aseptic filling and handling
Particle Free.
ISO 14644 Standards.
Designed to meet ISO 14644 particle control requirements, oVi™ vials undergo advanced particulate inspection systems to ensure freedom from visible and sub-visible particles. This level of control is critical for injectable and ophthalmic formulations.
Fully inspected for visible particles per USP <790>
Sub-visible particle control per USP <788> and EP 2.9.19
Ideal for sensitive and high-purity applications
Cytotoxicity Free.
ISO 10993-5 Biocompatibility Certified.
oVi™ vials meet the stringent cytotoxicity requirements outlined in ISO 10993-5, ensuring they are free from harmful substances that could adversely affect cell viability. This makes them ideal for applications in advanced therapeutics and cell-based assays.
Certified non-cytotoxic per ISO 10993-5
Supports cellular research and therapeutic development
Ensures compatibility with biologic formulations
Double Packed.
ISO 11607-Compliant Design.
The proprietary oVi™ double-packaging system is engineered for sterility assurance and ease of handling. Designed in compliance with ISO 11607, the packaging protects against environmental contaminants and supports aseptic operations.
Double-packaged to ensure sterility during transport and storage
Validated sealing integrity for long-term protection
Enhances aseptic handling in cleanroom environments
Worldwide Shipping.
Global Shipments.
oVi™ vials are available for shipment worldwide, ensuring timely delivery while adhering to regional regulatory standards. Our robust logistics network ensures products arrive securely and on schedule, ready for use in your critical applications.
Global distribution with end-to-end tracking
Compliance with international shipping and import regulations
Designed for uninterrupted supply chain reliability
Type 1 Glass.
Industry-Leading Material.
oVi™ vials are manufactured using Type 1 R Borosilicate Glass by our supplying partner, known for its superior chemical and thermal resistance. Available in multiple sizes, these vials meet USP, EP, and JP standards, making them suitable for a wide range of pharmaceutical and biologic applications.
Manufactured per ISO 8362 and USP <660> standards
High hydrolytic resistance for chemical stability
Range of sizes to accommodate various formulation needs
21 Units per Box.
Integrated Flexibility.
Each oVi™ box contains 21 sterile vials, individually packed to support non-simultaneous use. This design minimizes handling risks while offering flexibility for researchers and healthcare professionals managing varying project timelines.
21 units per box for controlled, efficient usage
Reduces contamination risks associated with bulk unpacking
Tailored for scalable research and production needs
EO Residual-Free.
Ensuring Purity and Safety
oVi™ vials are validated to be free of ethylene oxide (EO) residues, making them ideal for critical pharmaceutical and biotech applications. Our advanced sterilization processes undergo rigorous aeration cycles and EO residual testing to ensure compliance with stringent safety standards. Residual Testing Verified according to ISO 10993-7 to meet the lowest allowable limits for residual EO and ethylene chlorohydrin (ECH). Guaranteed Safety: Eliminates risks of residual EO affecting product quality or patient safety.
Recycling Program.
Supporting the Planet.
With oVi™, sustainability meets innovation. Traditional industrial packaging forces users to open sterile units simultaneously, often resulting in waste. oVi™ enables you to use only what you need, reducing material wastage.
Additionally, OpenVial offers a recycling program for subscription customers, further minimizing environmental impact.
5 Year Shelf Life.
Validated Stability.
oVi™ vials are designed with long-term reliability in mind. Each lot undergoes extensive stability testing to ensure a validated shelf life of five years, meeting the stringent requirements of pharmaceutical and biotech industries.
Stability data ensures maintained sterility, pyrogen-free status, and material integrity
Supports flexible usage timelines for research and production planning
With a 5-year validated shelf life, oVi™ provides the assurance of performance and quality, even for extended projects and storage requirements.
Batch Certification
Documentation for regulatory submissions and internal audits
At OpenVial, we recognize the critical importance of traceability and compliance in pharmaceutical R&D. For every batch of oVi™ vials, customers can request a full set of certifications, including sterility validation and laboratory test results. These certificates are designed to meet the stringent documentation standards of global pharmaceutical and biotech companies. Available Certifications include certificate of Sterility: Validates compliance with ISO 11137 sterilization standards and confirms sterility assurance level (SAL) of 10⁻⁶. Batch-Specific Laboratory Test Certificates including Endotoxin testing (USP <85>, EP 2.6.14), Cytotoxicity testing (ISO 10993-5), Particulate matter analysis (USP <788>, EP 2.9.19), Stability data, if applicable.
oVi by OpenVial.
Today from 449.-
oVi™ by OpenVial.
Founded in 2022 and headquartered in Switzerland, OpenVial™ is a company that develops, manufactures and markets packaging systems for injectable solutions. Businesses of every size—from new startups to corporations, use our products & services to lead healthcare innovation & maintain their development velocity.
All our products & services are created with a deep belief in excellence. We constantly improve our operations, test which attributes are most relevant, and release practical changes to keep up with the speed of innovation across the world. Throughout our entire supply chain, from the selection of raw materials to when our products are in use, OpenVial monitors and maintains a focus on every factor to create the best user-experience.